Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.410
-0.055 (-3.75%)
May 6, 2026, 5:22 PM CET

STO:NEWBRY Ratios and Metrics

Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
4379807887-
Market Cap Growth
-47.42%-1.65%2.52%-9.92%--
Enterprise Value
3367656548-
Last Close Price
1.412.593.304.004.44-
Forward PE
-13.45----
PS Ratio
1.312.492.177.6115.72-
PB Ratio
1.371.841.541.581.26-
P/TBV Ratio
33.916.6315.9521.124.73-
EV/Sales Ratio
1.002.121.766.358.70-
Net Debt / Equity Ratio
-0.32-0.34-0.29-0.17-0.48-0.34
Net Debt / EBITDA Ratio
0.440.741.120.482.40-
Asset Turnover
0.400.380.450.130.09-
Inventory Turnover
2.712.685.863.26--
Quick Ratio
0.861.161.272.045.633.57
Current Ratio
1.121.511.492.316.023.63
Return on Equity (ROE)
-74.88%-50.46%-30.41%-32.89%-27.35%-
Return on Assets (ROA)
-18.38%-15.31%-11.04%-14.17%-13.48%-
Return on Capital Employed (ROCE)
-69.50%-44.30%-23.60%-29.60%-17.30%-15.90%
Earnings Yield
-66.45%-30.34%-19.24%-24.88%-16.92%-
Buyback Yield / Dilution
-21.93%-21.08%-9.68%-9.68%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.